| EP0533862 - RECOMBINANT HUMAN FACTOR VIII DERIVATIVES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 25.08.2000 Database last updated on 01.04.2026 | Most recent event Tooltip | 25.08.2000 | No opposition filed within time limit | published on 11.10.2000 [2000/41] | Applicant(s) | For all designated states Pharmacia & Upjohn Aktiebolag 112 87 Stockholm / SE | [1997/50] |
| Former [1995/02] | For all designated states Pharmacia AB (reg.number 556131-9608) S-171 97 Stockholm / SE | ||
| Former [1993/13] | For all designated states KABI PHARMACIA AB S-751 82 Uppsala / SE | Inventor(s) | 01 /
ALMSTEDT, Annelie, B. Tegnérgatan 45 S-111 61 Stockholm / SE | 02 /
HELLSTRÖM, Eva, Maria Bergsgatan 3 S-112 23 Stockholm / SE | 03 /
LIND, Peter Ringgatan 47C S-752 27 Uppsala / SE | 04 /
LJUNG, Catherine Basgränd 17 S-162 46 Vällingby / SE | 05 /
SANDBERG, Helena, Inga Igelkottsvägen 21 S-161 37 Bromma / SE | 06 /
SPIRA, Jack Tottvägen 6 S-171 35 Stockholm / SE | 07 /
SYDOW-BÄCKMAN, Mona Knopvägen 1 S-133 44 Saltsjöbaden / SE | 08 /
WIMAN, Helena Krukmakargatan 27 S-118 51 Stockholm / SE | [1993/13] | Representative(s) | Burman, Tore, et al AWAPATENT AB, Box 45086 104 30 Stockholm / SE | [N/P] |
| Former [1997/50] | Burman, Tore, et al AWAPATENT AB, Box 45086 104 30 Stockholm / SE | ||
| Former [1995/02] | (deleted) | ||
| Former [1994/32] | Burman, Tore, et al AWAPATENT AB, Box 45086 S-104 30 Stockholm / SE | ||
| Former [1993/13] | Burman, Tore Awapatent AB Box 45086 S-104 30 Stockholm / SE | Application number, filing date | 92905708.1 | 11.03.1992 | [1993/13] | WO1992SE00150 | Priority number, date | SE19910000799 | 15.03.1991 Original published format: SE 9100799 | [1993/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9216557 | Date: | 01.10.1992 | Language: | EN | [1992/25] | Type: | A1 Application with search report | No.: | EP0533862 | Date: | 31.03.1993 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.10.1992 takes the place of the publication of the European patent application. | [1993/13] | Type: | B1 Patent specification | No.: | EP0533862 | Date: | 27.10.1999 | Language: | EN | [1999/43] | Search report(s) | International search report - published on: | SE | 01.10.1992 | Classification | IPC: | C07K14/00, C12N15/12, C12P21/02 | [1998/47] | CPC: |
C07K14/755 (EP);
A61P7/04 (EP)
|
| Former IPC [1993/13] | C07K13/00, C12N15/12, C12P21/02 | Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, MC, NL, SE [1993/13] | Title | German: | REKOMBINANTE DERIVATE DES MENSCHLICHEN FAKTORS VIII | [1993/13] | English: | RECOMBINANT HUMAN FACTOR VIII DERIVATIVES | [1993/13] | French: | DERIVES DU FACTEUR HUMAIN VIII RECOMBINE | [1993/13] | Biological material | This application mentions deposited biological material, check the file for details | Entry into regional phase | 19.10.1992 | National basic fee paid | 19.10.1992 | Designation fee(s) paid | 19.10.1992 | Examination fee paid | Examination procedure | 19.10.1992 | Examination requested [1993/13] | 26.02.1998 | Despatch of a communication from the examining division (Time limit: M06) | 05.08.1998 | Reply to a communication from the examining division | 16.12.1998 | Despatch of communication of intention to grant (Approval: No) | 15.04.1999 | Despatch of communication of intention to grant (Approval: later approval) | 27.04.1999 | Communication of intention to grant the patent | 25.06.1999 | Fee for grant paid | 25.06.1999 | Fee for publishing/printing paid | Opposition(s) | 28.07.2000 | No opposition filed within time limit [2000/41] | Fees paid | Renewal fee | 09.03.1994 | Renewal fee patent year 03 | 09.03.1995 | Renewal fee patent year 04 | 08.03.1996 | Renewal fee patent year 05 | 12.03.1997 | Renewal fee patent year 06 | 10.03.1998 | Renewal fee patent year 07 | 11.03.1999 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X] Proc. Natl. Acad. Sci., Vol. 83, May 1986, L.O. ANDERSSON: "Isolation and characterization of human factor VIII: Molecular forms in commercial factor VIII concentrate, cryoprecipitate and plasma", see pages 2979-2983. [X] | [A] The Journal of Biological Chemistry, 261(1986):27, R.L. BURKE et al., "The Functional Domains of Coagulation Factor VIII:C", pages 12574-12578. [A] | [A] Biochemistry, Vol. 25, No. 26, December 1986, D.L. EATON et al.: "Construction and Characterization of an Active Factor VIII variant Lacking the central One-Third of the Molecule", see pages 8343-8347. [A] |